Sotera Health Co
SHC
23 insider filings · Latest: May 26, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| May 13, 2026 | May 15 8:54 PM | WARBURG PINCUS & CO.Director, 10% Owner | Sale | 19,102,952 | $15.17 | $289.8M | 0(I) | View → |
| May 13, 2026 | May 15 8:48 PM | WARBURG PINCUS & CO.Director, 10% Owner | Sale | 19,102,952 | $15.17 | $289.8M | 0(I) | View → |
| May 13, 2026 | May 15 8:41 PM | GTCR INVESTMENT XI LLCDirector, 10% Owner | Sale | 12,735,301 | $15.17 | $193.2M | 0(I) | View → |
| Mar 6, 2026 | Mar 10 11:50 PM | WARBURG PINCUS & CO.Director, 10% Owner | Sale | 15,000,000 | $15.27 | $229.1M | 19,102,952(I) | View → |
| Mar 6, 2026 | Mar 10 11:49 PM | WARBURG PINCUS & CO.Director, 10% Owner | Sale | 15,000,000 | $15.27 | $229.1M | 19,102,952(I) | View → |
| Mar 6, 2026 | Mar 10 10:10 PM | GTCR INVESTMENT XI LLCDirector, 10% Owner | Sale | 10,000,000 | $15.27 | $152.7M | 12,735,301(I) | View → |
| Dec 8, 2025 | Dec 8 10:11 PM | Michael B. Petras, Jr. | Proposed Sale | 750,000 | $16.75 | $12.6M | — | View → |
| Dec 3, 2025 | Dec 4 11:01 AM | GTCR FUND XI/C LP | Proposed Sale | 1,295,747 | $16.33 | $21.2M | — | View → |
| Dec 3, 2025 | Dec 4 2:59 AM | GTCR CO-INVEST XI LP | Proposed Sale | 41,219 | $16.33 | $673.1K | — | View → |
| Dec 3, 2025 | Dec 4 2:59 AM | GTCR FUND XI/A LP | Proposed Sale | 5,143,033 | $16.33 | $84.0M | — | View → |
| Dec 3, 2025 | Dec 4 1:53 AM | WARBURG PINCUS LLC | Proposed Sale | 9,720,000 | $16.84 | $163.7M | — | View → |
| Aug 22, 2025 | Aug 22 2:46 PM | Rutz Michael P | Proposed Sale | 126,611 | $16.12 | $2.0M | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| May 26, 2026 | May 27 9:54 PM | Alton ShaderDirector, Chief Executive Officer | Grant/Award | 101,817 | — | 101,817(D) | View → |
| Mar 2, 2026 | Mar 5 2:17 AM | Michael B. Petras Jr.Director, Chairman & CEO | Grant/Award | 120,124 | — | 120,124(D) | View → |
| Mar 2, 2026 | Mar 5 2:17 AM | Michael B. Petras Jr.Director, Chairman & CEO | Option Exercise | 89,686 | — | 59,790(D) | View → |
| Mar 2, 2026 | Mar 5 1:55 AM | Alexander DimitriefSVP, General Counsel and Sec. | Option Exercise | 16,816 | — | 11,210(D) | View → |
| Mar 2, 2026 | Mar 5 1:54 AM | Jonathan M. LyonsSr. Vice President, CFO | Option Exercise | 17,937 | — | 11,958(D) | View → |
| Mar 2, 2026 | Mar 5 1:54 AM | Jonathan M. LyonsSr. Vice President, CFO | Grant/Award | 29,678 | — | 29,678(D) | View → |
| Mar 2, 2026 | Mar 5 1:51 AM | Michael P RutzPresident of Sterigenics | Grant/Award | 22,612 | — | 22,612(D) | View → |
| Mar 2, 2026 | Mar 5 1:51 AM | Michael P RutzPresident of Sterigenics | Option Exercise | 14,573 | — | 9,716(D) | View → |